Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants

Clinical trial NCT01763268 · UNKNOWN

Trial details

NCT number: NCT01763268
Sponsor: Queen Sirikit National Institute of Child Health
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Immunogenicity Reactogenicity

Start date: 2012-09-01
Primary completion: 2015-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.